Fotemustine in Treating Patients With Metastatic Melanoma
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as fotemustine, work in different ways to stop
the growth of tumor cells, either by killing the cells or by stopping them from dividing.
Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors
predict how well patients will respond to treatment.
PURPOSE: This phase II trial is studying fotemustine to see how well it works in treating
patients with metastatic melanoma.